Previous 10 | Next 10 |
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
IQVIA Holdings Inc. (IQV) is expected to report $2.21 for Q3 2023
2023-11-01 02:25:00 ET Summary Despite an okay earnings season thus far, stocks are bearing the brunt of softening investor sentiment and corporate uncertainty. This week, 2,357 companies are expected to report for Q3, 170 from the S&P 500. Potential Surprises this week: C...
2023-10-31 12:33:41 ET More on IQVIA IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term IQVIA Holdings Q2: Breaking Ground And Beating Expectations HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead For further detai...
2023-10-25 09:58:55 ET More on Veeva Systems Veeva: Some Underappreciated Growth Opportunities Veeva Systems: A Lot Of Growth Opportunities Remain Veeva Systems: Its Strong Moat Might Extend To The SMB Sector Pfizer cutting expenses likely 'manageable' for Ve...
2023-10-25 09:45:00 ET Summary Cedar Creek Partners is a private investment partnership that focuses primarily on micro and small cap equities. Cedar Creek Partners is managed by Eriksen Capital Management LLC, a registered investment adviser. Major indices were negative in Q3, bu...
Sanofi to use IQVIA’s CRM platform to maximize customer interactions and innovate in the retail channel IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life scienc...
2023-10-14 10:45:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
CEPI will harness IQVIA’s expertise and resources in implementing global clinical research strategies and procedures to rapidly initiate clinical evidence generation around vaccines and other biological countermeasures in response to future health emergencies. Collaboration will al...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings rel...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...